Contralateral Occluded Carotid Defines Revascularization Strategy

A significative lesion to the carotid artery in addition to contralateral carotid occlusion is an obvious factor of high risk for a revascularization procedure. However, this might be true for surgery but not for carotid artery stenting according to this recent publication in JACC.

Carótida ocluida contralateral define la estrategia de revascularización

The presence of contralateral carotid occlusion has been established as high risk for patients undergoing carotid endarterectomy, even though recent observational studies have cast a shadow on this paradigm. 

The aim of this study was to determine the clinical impact of contralateral occlusion in contemporary patients receiving endarterectomy or carotid artery stenting.  

All patients from a national registry receiving carotid revascularization presenting contralateral occlusion were included. 

Primary end point was a combination of death, stroke and MI.


Read also: Solution for Type 1A Endoleaks After Abdominal Endoprosthesis.


Of 58423 patients undergoing carotid revascularization, 7.9% (n=4624) had contralateral occlusion. Among these, 68.9% (n=3185) received surgery and 31.1% (n=1439) carotid artery stenting. Nearly half of patients (45.4%) presented with symptomatic disease because of prior stroke of transient ischemic attack. 

After multiple adjustments of different variables, researchers observed that a history of contralateral occlusion was associated with 71% increased events risk after endarterectomy (p<0.001), vs. no increased risk with carotid artery stenting (OR 0.94; CI 95%, p=0.64).

Conclusion

Contralateral carotid occlusion is an important risk factor for patients undergoing endarterectomy but no for patients receiving carotid artery stenting. This factor should be taken into account when deciding for or against a revascularization strategy. 

Original Title: Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.

Reference: Anna K Krawisz et al. J Am Coll Cardiol. 2021 Feb 23;77(7):835-844. doi: 10.1016/j.jacc.2020.12.032.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....